These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24838036)

  • 1. Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent.
    De Maria E; Diemberger I; Vassallo PL; Pastore M; Giannotti F; Ronconi C; Romandini A; Biffi M; Martignani C; Ziacchi M; Bonfatti F; Tumietto F; Viale P; Boriani G
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):554-64. PubMed ID: 24838036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
    Manolis AS; Melita H
    Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
    Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S;
    Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.
    Birnie DH; Wang J; Alings M; Philippon F; Parkash R; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; Exner DV; Dorian P; Connolly SJ; Longtin Y; Krahn AD
    J Am Coll Cardiol; 2019 Dec; 74(23):2845-2854. PubMed ID: 31806127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac implantable devices: surveillance of surgical site infections and assessment of professional practices.
    Metais M; Hebrard A; Duparc A; Mondoly P; Delay M; Lepage B; Malavaud S
    Arch Cardiovasc Dis; 2011 May; 104(5):325-31. PubMed ID: 21693369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prophylaxis topical antibiotics in cardiac device implantation.
    Khalighi K; Aung TT; Elmi F
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):304-11. PubMed ID: 24164587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center.
    Cengiz M; Okutucu S; Ascioglu S; Sahin A; Aksoy H; Sinan Deveci O; Baris Kaya E; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Clin Cardiol; 2010 Jul; 33(7):406-11. PubMed ID: 20641117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof positive: efficacy of antibiotic prophylaxis in device implantation.
    Maytin M; Epstein LM
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):4-5. PubMed ID: 19808438
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.
    Tarakji KG; Wilkoff BL
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):607-16. PubMed ID: 23621142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
    Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
    Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular implantable electronic device associated infections.
    Gandhi T; Crawford T; Riddell J
    Infect Dis Clin North Am; 2012 Mar; 26(1):57-76. PubMed ID: 22284376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
    Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections of cardiac implantable electronic devices: Epidemiology, classification, treatment, and prognosis.
    Sławiński G; Lewicka E; Kempa M; Budrejko S; Raczak G
    Adv Clin Exp Med; 2019 Feb; 28(2):263-270. PubMed ID: 30048058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.
    Greenspon AJ; Patel JD; Lau E; Ochoa JA; Frisch DR; Ho RT; Pavri BB; Kurtz SM
    J Am Coll Cardiol; 2011 Aug; 58(10):1001-6. PubMed ID: 21867833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Infections Associated With Intracardiac Devices. Toward a Rationalization of Clinical Practice.
    Fernández-Hidalgo N
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):797-799. PubMed ID: 31402329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.